Venetoclax-Proteasome inhibitor-Dexamethasone for unfit patients with Blastic Plasmacytoid Dendritic Cell Neoplasm
Blood Adv
.
2024 Dec 4:bloodadvances.2024014590.
doi: 10.1182/bloodadvances.2024014590.
Online ahead of print.
Authors
Sabine Khalife-Hachem
1
,
Arnaud Pages
2
,
Elie Akoury
2
,
Sarah Bonnet
3
,
Rudy Birsen
4
,
Clemence Busquet
5
,
Adrien Contejean
6
,
Alina Danu
7
,
Stéphane De Botton
2
,
Marie De Charette
8
,
Pierre-Yves Dumas
9
,
Arnaud Jaccard
10
,
Anne Marfaing-Koka
11
,
Christophe Willekens
12
,
Eric Deconinck
13
,
David Ghez
12
Affiliations
1
Gustave Roussy, NEUILLY SUR SEINE, France.
2
Institut Gustave Roussy, Villejuif, France.
3
CHU Montpellier, Montpellier, France.
4
Assistance publique-hopitaux de Paris, Hopital Cochin, Service d'hématologie clinique, Paris, France.
5
CHU de Limoges, Limoges, France.
6
Clinical Hematology, Annecy Genevois Hospital, Epagny Metz-Tessy, France.
7
Gustave Roussy, VILLEJUIF, France.
8
CHU LA RÉUNION, Saint Denis, France.
9
CHU Bordeaux, Service d'Hématologie Clinique et Thérapie cellulaire, F-33000, Bordeaux, France, PESSAC, France.
10
Hôpital Cochin, France.
11
Hopital Antoine Beclère, Clamart, France.
12
Gustave Roussy, Villejuif, France.
13
Centre Hospitalier Universitaire Besancon, Besancon, France.
PMID:
39642332
DOI:
10.1182/bloodadvances.2024014590
No abstract available